Grow

Search This Blog

A vaccine from Sanofi and GSK is said to produce strong immune responses in a mid-stage study.

May 17, 2021

Get link
Facebook
X
Pinterest
Email
Other Apps

By Rebecca Robbins | NYTimes | NYT > Business | Disclosure

A Phase 3 trial will start in the coming weeks. The drug makers expect their shot will become available in the last three months of this year. IFTTT NYT NYT > Business NYTimes

Get link
Facebook
X
Pinterest
Email
Other Apps

Comments

Kay Koplovitz Wants to See More Entrepreneurs Who Look Like Her

Once the most powerful woman in television, the founder of Springboard has spent the past 20 years identifying and funding female-led start-ups. By Sarah Kessler | NYTimes | Business | Disclosure

Inside the Four-Day Workweek Experiment

A British group is pushing for more companies to offer their workers shorter hours. Here’s what it looks like for two companies willing to test it out. By Isabella Kwai and Tom Jamieson For The New York Times | NYTimes Business | Disclosure

Stellantis and Samsung Will Get $7 Billion to Build Battery Factories

The loan, from the Biden administration, was designed to withstand Republican attacks and will be used to make electric-car batteries in Indiana. By Jack Ewing | NYTimes | Business | Disclosure

Italy Is Having an Election. Most Italians Are Too Depressed to Care.

By PETER S. GOODMAN via NYT Business Day

Debate Over U.S. Sanctions on Russia For Ukraine War Intensifies

The president-elect has said he will use sanctions sparingly while vowing to end the war in Ukraine, renewing questions over their efficacy. By Patricia Cohen | NYTimes | NYT > Business | Disclosure

A vaccine from Sanofi and GSK is said to produce strong immune responses in a mid-stage study.

Comments

Post a Comment